Advertisement

MIR-140-5p affects chondrocyte proliferation, apoptosis, and inflammation by targeting HMGB1 in osteoarthritis

  • Yingjie Wang
  • Songpo Shen
  • Zeng Li
  • Weifeng Li
  • Xisheng WengEmail author
Original Research Paper
  • 85 Downloads

Abstract

Objective

This study aimed to test the expression and biological function of miR-140-5p in osteoarthritis (OA), and identify its target gene and explore its mechanism in OA.

Methods

Differential genes were screened and analyzed by gene microarray and WGCNA analysis. The normal human chondrocytes C28/I2 were induced by IL-1β to construct the OA cell model. The expression of miR-140-5p and high mobility group box 1 (HMGB1) was quantified by quantitative real-time PCR (qRT-PCR) in OA tissues and IL-1β-induced chondrocytes. Western blotting was performed to evaluate the expression of HMGB1 and PI3K/AKT pathway activation. The concentrations of tumor necrosis factor (TNF)-α, interleukin (IL)-6, MMP-1 and MMP-3 were determined by ELISA. CCK-8 and flow cytometry were conducted to determine the cellular capabilities of proliferation and cell apoptosis.

Results

Bioinformatics analysis demonstrated that HMGB1 was highly expressed in OA and activated PI3K/AKT pathway. Also, HMGB1 was predicted as a target of miR-140-5p. The levels of miR-140-5p were negatively correlated with HMGB1 in OA tissues and IL-1β-induced chondrocytes. The overexpression of miR-140-5p reduced the expression of HMGB1 protein, p-AKT (Ser473) and p-PI3K in IL-1β-induced chondrocytes. Besides, the expression of p-AKT (Ser473) and p-PI3K was significantly upregulated by employing miR-140-5p inhibitor, but retrieved after treating with LY294002. Furthermore, miR-140-5p inhibited inflammation, matrix metalloprotease expression and apoptosis in IL-1β-induced chondrocytes through regulating HMGB1.

Conclusion

MiR-140-5p was down-regulated while HMGB1 was upregulated in OA. MiR-140-5p could inhibit the PI3K/AKT signaling pathway and suppress the progression of OA through targeting HMGB1.

Keywords

Osteoarthritis MiR-140-5p HMGB1 PI3K/AKT signaling pathway 

Notes

Acknowledgements

The study was supported by Natural Science Foundation of China [Grant Numbers: 81630064; 81871786].

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of Peking Union Medical College Hospital and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet (London, England). 2015;386(9991):376–87.  https://doi.org/10.1016/S0140-6736(14)60802-3.CrossRefGoogle Scholar
  2. 2.
    Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 2004;50(1):131–41.  https://doi.org/10.1002/art.11433.CrossRefPubMedGoogle Scholar
  3. 3.
    Zeng GQ, Chen AB, Li W, Song JH, Gao CY. High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis. Genet Mol Res. 2015;14(4):14811–22.  https://doi.org/10.4238/2015.November.18.46.CrossRefPubMedGoogle Scholar
  4. 4.
    Fu Y, Lei J, Zhuang Y, Zhang K, Lu D. Overexpression of HMGB1 A-box reduced IL-1beta-induced MMP expression and the production of inflammatory mediators in human chondrocytes. Exp Cell Res. 2016;349(1):184–90.  https://doi.org/10.1016/j.yexcr.2016.10.014.CrossRefPubMedGoogle Scholar
  5. 5.
    Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42.  https://doi.org/10.1038/nrrheum.2010.196.CrossRefPubMedGoogle Scholar
  6. 6.
    Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–11.  https://doi.org/10.1002/1529-0131(200004)43:4%3c801:AID-ANR10%3e3.0.CO;2-4.CrossRefPubMedGoogle Scholar
  7. 7.
    Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.  https://doi.org/10.1016/s0092-8674(04)00045-5.CrossRefPubMedGoogle Scholar
  8. 8.
    Fioravanti A, Collodel G, Petraglia A, Nerucci F, Moretti E, Galeazzi M. Effect of hydrostatic pressure of various magnitudes on osteoarthritic chondrocytes exposed to IL-1beta. Indian J Med Res. 2010;132:209–17.PubMedGoogle Scholar
  9. 9.
    Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthr Cartil. 2009;17(4):464–72.  https://doi.org/10.1016/j.joca.2008.09.012.CrossRefPubMedGoogle Scholar
  10. 10.
    Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord. 2009;10:148.  https://doi.org/10.1186/1471-2474-10-148.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Proctor CJ, Smith GR. Computer simulation models as a tool to investigate the role of microRNAs in osteoarthritis. PLoS One. 2017;12(11):e0187568.  https://doi.org/10.1371/journal.pone.0187568.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Yin X, Wang JQ, Yan SY. Reduced miR26a and miR26b expression contributes to the pathogenesis of osteoarthritis via the promotion of p65 translocation. Mol Med Rep. 2017;15(2):551–8.  https://doi.org/10.3892/mmr.2016.6035.CrossRefPubMedGoogle Scholar
  13. 13.
    Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180–95.  https://doi.org/10.7150/thno.17133.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, et al. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol. 2014;10(6):713–27.  https://doi.org/10.1586/1744666X.2014.909730.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Garcia-Arnandis I, Guillen MI, Gomar F, Pelletier JP, Martel-Pelletier J, Alcaraz MJ. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther. 2010;12(4):R165.  https://doi.org/10.1186/ar3124.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ley C, Ekman S, Roneus B, Eloranta ML. Interleukin-6 and high mobility group box protein-1 in synovial membranes and osteochondral fragments in equine osteoarthritis. Res Vet Sci. 2009;86(3):490–7.  https://doi.org/10.1016/j.rvsc.2008.10.008.CrossRefPubMedGoogle Scholar
  17. 17.
    Heinola T, Kouri VP, Clarijs P, Ciferska H, Sukura A, Salo J, et al. High mobility group box-1 (HMGB-1) in osteoarthritic cartilage. Clin Exp Rheumatol. 2010;28(4):511–8.PubMedGoogle Scholar
  18. 18.
    Li ZC, Cheng GQ, Hu KZ, Li MQ, Zang WP, Dong YQ, et al. Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis. Clin Invest Med. 2011;34(5):E298.CrossRefGoogle Scholar
  19. 19.
    Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193–204.  https://doi.org/10.1016/j.ctrv.2003.07.007.CrossRefPubMedGoogle Scholar
  20. 20.
    Chen J, Crawford R, Xiao Y. Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis. J Cell Biochem. 2013;114(2):245–9.  https://doi.org/10.1002/jcb.24362.CrossRefPubMedGoogle Scholar
  21. 21.
    Chen D, Zeng S, Huang M, Xu H, Liang L, Yang X. Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. J Cell Mol Med. 2017;21(4):781–90.  https://doi.org/10.1111/jcmm.13020.CrossRefGoogle Scholar
  22. 22.
    Lv DJ, Song XL, Huang B, Yu YZ, Shu FP, Wang C, et al. HMGB1 promotes prostate cancer development and metastasis by interacting with brahma-related gene 1 and activating the Akt signaling pathway. Theranostics. 2019;9(18):5166–82.  https://doi.org/10.7150/thno.33972.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lu L, Zhang D, Xu Y, Bai G, Lv Y, Liang J. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;104:613–21.  https://doi.org/10.1016/j.biopha.2018.05.087.CrossRefGoogle Scholar
  24. 24.
    He W, Cheng Y. Inhibition of miR-20 promotes proliferation and autophagy in articular chondrocytes by PI3K/AKT/mTOR signaling pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;97:607–15.  https://doi.org/10.1016/j.biopha.2017.10.152.CrossRefGoogle Scholar
  25. 25.
    Salmon JH, Rat AC, Sellam J, Michel M, Eschard JP, Guillemin F, et al. Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. Osteoarthr Cartil. 2016;24(9):1500–8.  https://doi.org/10.1016/j.joca.2016.03.012.CrossRefPubMedGoogle Scholar
  26. 26.
    Si H, Zeng Y, Zhou Z, Pei F, Lu Y, Cheng J, et al. Expression of miRNA-140 in chondrocytes and synovial fluid of knee joints in patients with osteoarthritis. Chin Med Sci J. 2016;31(4):207–12.CrossRefGoogle Scholar
  27. 27.
    Zhang M, Liu L, Xiao T, Guo W. Detection of the expression level of miR-140 using realtime fluorescent quantitative PCR in knee synovial fluid of osteoarthritis patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(12):1210–4.  https://doi.org/10.3969/j.issn.1672-7347.2012.12.005.CrossRefPubMedGoogle Scholar
  28. 28.
    Li X, Zhen Z, Tang G, Zheng C, Yang G. MiR-29a and MiR-140 protect chondrocytes against the anti-proliferation and cell matrix signaling changes by IL-1β. Mol Cells. 2016;39(2):103–10.  https://doi.org/10.14348/molcells.2016.2179.CrossRefPubMedGoogle Scholar
  29. 29.
    Liang Y, Duan L, Xiong J, Zhu W, Liu Q, Wang D, et al. E2 regulates MMP-13 via targeting miR-140 in IL-1beta-induced extracellular matrix degradation in human chondrocytes. Arthritis Res Ther. 2016;18(1):105.  https://doi.org/10.1186/s13075-016-0997-y.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006;26(2):174–9.  https://doi.org/10.1097/01.shk.0000225404.51320.82.CrossRefPubMedGoogle Scholar
  31. 31.
    Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101(7):2652–60.  https://doi.org/10.1182/blood-2002-05-1300.CrossRefPubMedGoogle Scholar
  32. 32.
    Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta. 1990;1052(3):366–78.  https://doi.org/10.1016/0167-4889(90)90145-4.CrossRefPubMedGoogle Scholar
  33. 33.
    Terada C, Yoshida A, Nasu Y, Mori S, Tomono Y, Tanaka M, et al. Gene expression and localization of high-mobility group box chromosomal protein-1 (HMGB-1)in human osteoarthritic cartilage. Acta Med Okayama. 2011;65(6):369–77.  https://doi.org/10.18926/AMO/47262.CrossRefPubMedGoogle Scholar
  34. 34.
    Wahamaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, et al. High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther. 2011;13(4):R136.  https://doi.org/10.1186/ar3450.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Yuan Z, Luo G, Li X, Chen J, Wu J, Peng Y. PPARgamma inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. Cell Signal. 2016;28(3):158–64.  https://doi.org/10.1016/j.cellsig.2015.12.013.CrossRefPubMedGoogle Scholar
  36. 36.
    Yu F, Zeng H, Lei M, Xiao DM, Li W, Yuan H, et al. Effects of SIRT1 gene knock-out via activation of SREBP2 protein-mediated PI3K/AKT signaling on osteoarthritis in mice. J Huazhong Univ Sci Technol Med Sci. 2016;36(5):683–90.  https://doi.org/10.1007/s11596-016-1645-0.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Yingjie Wang
    • 1
  • Songpo Shen
    • 2
  • Zeng Li
    • 1
  • Weifeng Li
    • 1
  • Xisheng Weng
    • 1
    Email author
  1. 1.Department of OrthopedicsPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical ScienceBeijingChina
  2. 2.Department of OrthopedicsBeijing Tongren Hospital, Capital Medical UniversityBeijingChina

Personalised recommendations